SuperworthThe Sherwin-Williams Company SHW
Chemicals - Specialty, Basic Materials
$313.35
−0.52%
- Market cap
- $76.1B
- PE
- 29.0×
- 10y median 33.3×
- Forward PE
- Price to sales
- 3.1×
- EV/EBIT
- 21.5×
- Revenue, 12 months
- $24.4B
- +6% on a year ago
- Net margin
- 11.0%
- Free cash flow yield
- 4.2%
Sherwin-Williams trades at 29.0× trailing earnings, cheaper than 75% of the last ten years. Revenue was $24.4B over the last twelve months, up 6% on a year earlier with a 11% net margin.
Charts
Financials
| Income statement | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $5.3B | $5.4B | $6.3B | $6.2B | $5.3B+1% | $5.3B−1% | $6.3B+1% | $6.4B+3% | $5.6B+6% | $5.7B+7% | $6.8B+8% | |
| Cost of revenue | $2.7B | $2.8B | $3.2B | $3.1B | $2.7B+1% | $2.7B−3% | $3.2B−0% | $3.2B+3% | $2.9B+6% | $2.9B+5% | $3.5B+8% |
| Gross profit | $2.5B | $2.5B | $3.1B | $3B | $2.6B+1% | $2.6B+1% | $3.1B+2% | $3.1B+3% | $2.7B+5% | $2.8B+9% | $3.3B+7% |
| SG&A | $1.9B | $1.8B | $1.8B | $1.9B | $1.9B+2% | $1.8B−0% | $2B+9% | $2B+3% | $1.9B+3% | $2B+10% | $2.1B+5% |
| $674.6M | $725.8M | $1.2B | $1.1B | $673.5M−0% | $754.3M+4% | $1.1B−11% | $1.2B+4% | $778.7M+16% | $810.9M+8% | $1.2B+12% | |
| Interest expense | $94.6M | $106.3M | $115.2M | $107M | $102.9M+9% | $107.7M+1% | $112.4M−2% | $117.2M+10% | $131.6M+28% | $131.6M+22% | $135.9M+21% |
| Pre-tax income | $474M | $640M | $1.2B | $1B | $615.6M+30% | $653M+2% | $985.7M−16% | $1.1B+4% | $639M+4% | $679.8M+4% | $1.1B+13% |
| $117.8M | $134.8M | $283.5M | $216.6M | $135.5M+15% | $149.1M+11% | $231M−19% | $227.4M+5% | $162.2M+20% | $145.1M−3% | $268.9M+16% | |
| Net income | $356.2M | $505.2M | $889.9M | $806.2M | $480.1M+35% | $503.9M−0% | $754.7M−15% | $833.1M+3% | $476.8M−1% | $534.7M+6% | $843.6M+12% |
| $1.39 | $1.97 | $3.50 | $3.18 | $1.90+37% | $2.00+2% | $3.00−14% | $3.35+5% | $1.92+1% | $2.15+8% | $3.43+14% | |
| 256.9M | 255.8M | 254.2M | 253.9M | 254.1M−1% | 252.5M−1% | 251.3M−1% | 249M−2% | 248.8M−2% | 248.1M−2% | 246M−2% |
From each company's 10-Q and 10-K filings. Fiscal years are four fiscal quarters added up; balance sheet lines are as of the period's end. Growth is on the same period a year earlier.
Estimates
Next earnings report: .
Analyst consensus for the next eight quarters, with the range from the lowest to the highest estimate, is part of Superworth Pro.
Peers
Companies in Chemicals - Specialty within ten times Sherwin-Williams's size, closest in size first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| SHWThe Sherwin-Williams Company | $76.5B | 29.0× | 33.3× | 3.1× | +6% | 11.0% | |
| ECLEcolab Inc. | $78B | 37.3× | 37.3× | 4.6× | +7% | 12.6% | |
| LINLinde plc | $223.1B | 31.3× | 34.8× | 6.3× | +7% | 20.4% | |
| PPGPPG Industries, Inc. | $23.4B | 15.1× | 23.9× | 1.4× | +5% | 9.6% | |
| IFFInternational Flavors & Fragrances Inc. | $21.5B | 77.2× | 36.5× | 2.2× | −12% | 2.8% | |
| Peer median | $50.7B | 34.3× | 35.6× | 3.4× | +6% | 11.1% |
About
- Industry
- Chemicals - Specialty
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .